Average: 5 (1 vote)

Management of Secondary Hyperparathyroidism in Chronic Kidney Disease

Course description

This activity will address the clinical challenge of preventing and treating SHPT in patients with CKD. Content will review pathophysiology and consequences of SHPT, and address modifiable causes and management goals for improved patient outcomes. The activity will examine the safety and efficacy of current treatment options, and will provide insight to recent clinical evidence for a novel peptide agonist of the calcium sensing receptor for the management of SHPT in patients with CKD.

Learning Objectives: 

After participation in this activity, learners will be able to:

  • Determine and evaluate the risk of adverse outcomes associated with SHPT and abnormal mineral metabolism in CKD
  • Identify risks and benefits of established treatments for SHPT to attain the best treatment options for individual patients
  • Recognize the potential role of emerging strategies to manage SHPT in CKD to promote optimal patient outcomes and minimize adverse events 

Once you're logged in the "ADD TO CART" button can be found at the bottom of this webpage.

Target audience: 
  • Physicians
  • Physician Assistants
  • Nurse Practitioners
  • Nurses
  • Dietitians
CME/CE Information:


The National Kidney Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Kidney Foundation designates this enduring for a maximum of 1.0 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Physician Assistant

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.

Nurse Practitioners

This program is approved for 1.0 contact hours of continuing education (which includes 0.08 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 16042171.

This program was planned in accordance with AANP CE Standards and Policies.  


The National Kidney Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hours of continuing nursing education (includes 0.08 contact hour in the area of pharmacology).


The National Kidney Foundation is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).  CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education Units (CPEUs) for completion of this activity/material.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required) and evaluation to successfully earn credit.  The estimated time for completion is 1.0 hours. 

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Credits & accreditation
  • 1.00 AANP Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 0.08 AANP Pharmacology
  • 0.08 ANCC Pharmacology
  • 1.00 Category I Credit for Physician Assistants
  • 1.00 CDR CPEUs
Faculty & disclosure
Faculty Disclosures:

Geoffrey A. Block, MD
Director of Research
Denver Nephrolgoist PC
Denver, CO
Disclosure: Is a member of the steering committee for Amgen; and is a consultant for Keryx and Ardelyx.

Linda McCann, RD, CSR
Nephrology Nutrition Consultant/Speaker
Eagle, ID
Disclosure: Is a member of the speakers bureau for Amgen; and is an advisory board member for FMC-Vifor and Relypsa.

Planning Committee Disclosures:

Kim Deaver, MSN, RN, CNN
Nurse Manager
University of Virginia Health System
Swoope, VA
Disclosure: No financial relationships with commercial interest(s).

Deborah Brommage, MS, RD, CSR, CDN
Program Director
National Kidney Foundation
New York, NY
Disclosure: No financial relationships with commercial interest(s).

CME/CE Reviewer Disclosures:

Norman Silas, MD, MPH
Associate Professor
University of Michigan
Ann Arbor, MI
Disclosures: No financial relationships with commercial interest(s).

Laly Joseph, DVM, DNP, APRN, B.C.
Assistant Professor
University of Miami
Miami, FL
Disclosures: No financial relationships with commercial interest(s).

Thessa Churillo, RD, CSR
Renal Dietitian
Compass (Morrison)
Charlottesville, VA
Disclosure: No financial relationships with commercial interest(s)

Supported by an educational grant by Amgen.

Additional information
Required hardware / software: 

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit

For additional professional education resources, contact NKF at 1-800-622-9010 or visit 

Course summary
Available credit: 
  • 1.00 AANP Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Nurse Contact Hours
  • 1.00 Attendance
  • 0.08 AANP Pharmacology
  • 0.08 ANCC Pharmacology
  • 1.00 Category I Credit for Physician Assistants
  • 1.00 CDR CPEUs
Course opens: 
Course expires: 

Enrollment Restricted

Please login or register for a PERC account to take this course.